Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 28% ± 9% | |
| dendritic cell | 3 studies | 19% ± 4% | |
| basal cell | 3 studies | 20% ± 4% | |
| plasmacytoid dendritic cell | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 820.88 | 226 / 226 | 100% | 16.29 | 406 / 406 |
| ovary | 100% | 1358.43 | 180 / 180 | 100% | 16.48 | 430 / 430 |
| prostate | 100% | 1435.87 | 245 / 245 | 100% | 36.19 | 502 / 502 |
| thymus | 100% | 1242.54 | 653 / 653 | 100% | 31.44 | 605 / 605 |
| brain | 100% | 1168.56 | 2641 / 2642 | 100% | 35.17 | 705 / 705 |
| skin | 100% | 983.73 | 1808 / 1809 | 100% | 32.37 | 472 / 472 |
| uterus | 100% | 1147.86 | 170 / 170 | 100% | 27.04 | 458 / 459 |
| pancreas | 100% | 582.35 | 327 / 328 | 100% | 19.69 | 178 / 178 |
| stomach | 100% | 875.29 | 359 / 359 | 100% | 16.81 | 285 / 286 |
| bladder | 100% | 1124.43 | 21 / 21 | 100% | 26.40 | 502 / 504 |
| adrenal gland | 100% | 1960.50 | 258 / 258 | 100% | 27.37 | 229 / 230 |
| breast | 100% | 1009.16 | 459 / 459 | 100% | 24.93 | 1113 / 1118 |
| esophagus | 100% | 969.13 | 1445 / 1445 | 99% | 10.75 | 182 / 183 |
| kidney | 100% | 1177.90 | 89 / 89 | 99% | 18.14 | 896 / 901 |
| intestine | 100% | 1054.07 | 966 / 966 | 99% | 21.56 | 524 / 527 |
| lung | 99% | 820.32 | 573 / 578 | 100% | 18.01 | 1153 / 1155 |
| eye | 0% | 0 | 0 / 0 | 100% | 29.54 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 46.29 | 29 / 29 |
| spleen | 100% | 1208.55 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 21.45 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 20.50 | 1 / 1 |
| adipose | 100% | 920.63 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 913.98 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 914.43 | 801 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 818.59 | 848 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 87% | 694.92 | 807 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0002098 | Biological process | tRNA wobble uridine modification |
| GO_0030335 | Biological process | positive regulation of cell migration |
| GO_0008150 | Biological process | biological_process |
| GO_0006417 | Biological process | regulation of translation |
| GO_0005829 | Cellular component | cytosol |
| GO_0033588 | Cellular component | elongator holoenzyme complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | ELP6 |
| Protein name | Elongator complex protein 6 Elongator acetyltransferase complex subunit 6 Elongator complex protein 6 (Angiotonin-transactivated protein 1) (Protein TMEM103) |
| Synonyms | TMEM103 C3orf75 ATP1 |
| Description | FUNCTION: Component of the elongator complex which is required for multiple tRNA modifications, including mcm5U (5-methoxycarbonylmethyl uridine), mcm5s2U (5-methoxycarbonylmethyl-2-thiouridine), and ncm5U (5-carbamoylmethyl uridine) . The elongator complex catalyzes formation of carboxymethyluridine in the wobble base at position 34 in tRNAs . Involved in cell migration (By similarity). . |
| Accessions | ENST00000442215.6 C9JEX8 ENST00000439305.5 ENST00000412761.5 Q0PNE2 C9JA82 ENST00000449409.5 ENST00000296149.9 [Q0PNE2-1] F8WE64 ENST00000446787.5 C9J9N8 ENST00000425291.5 C9J2D6 H7BZM9 ENST00000444760.5 C9JLH5 ENST00000414236.5 ENST00000445044.5 C9IYN7 |